{
    "name": "Pharma Process",
    "children": [
      {
        "name": "Research",
        "children": [
          {
            "name": "Portfolio & Pipeline Management",
            "children": [
              {
                "name": "Strategic Planning",
                "children": [
                  {
                    "name": "Portfolio Prioritization, Budget planning, Resource allocation",
                    "children": []
                  },
                  {
                    "name": "Competitors Landscape, Risk Benefit analysis, Business alignment",
                    "children": []
                  },
                  {
                    "name": "Patent validation, clinical competition landscape, is it a drugable target, Market valuation",
                    "children": []
                  },
                  {
                    "name": "Data-driven evaluation, Milestone tracking, Stakeholder alignment, Decision documentation",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "name": "Drug discovery",
            "children": [
              {
                "name": "Therapeutic area: Disease,Target Discovery",
                "children": [
                  {
                    "name": "Target Identification, Target Validation Go/No-Go Decision Framework",
                    "children": []
                  },
                  {
                    "name": "Computational Drug Design, AI/ML-based Drug Screening, Structure-Based Drug Design",
                    "children": []
                  },
                  {
                    "name": "Laboratory Information Management System (LIMS) and Sample management",
                    "children": []
                  },
                  {
                    "name": "High-Throughput Screening (HTS) Medium-Throughput Screening (MTS) Fragment-Based Screening (FBS) High Concentration Screening",
                    "children": []
                  },
                  {
                    "name": "Hit Identification & Optimization",
                    "children": []
                  },
                  {
                    "name": "Medicinal chemisty, Lead Compound Optimization and SAR (structure activity relationship)",
                    "children": []
                  },
                  {
                    "name": "Mechanism of Action (MoA) Studies",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "name": "Preclinical development",
            "children": [
              {
                "name": "Preclinical testing",
                "children": [
                  {
                    "name": "Preclinical In vitro and in vivo assays",
                    "children": []
                  },
                  {
                    "name": "PK-PD studies",
                    "children": []
                  },
                  {
                    "name": "Toxicology and Safety Assessment,Efficacy Testing",
                    "children": []
                  }
                ]
              },
              {
                "name": "Process R&D",
                "children": [
                  {
                    "name": "Scaling,  profiling, polymorphism studies",
                    "children": []
                  }
                ]
              },
              {
                "name": "Documentation",
                "children": [
                  {
                    "name": "Patent filing, regulatory document ",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  }
  